Vivani Medical (VANI) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VANI Vivani Medical

Watchlist

1.300
+0.040+3.17%

Close Jul 22 16:00 ET

1.330
+0.030+2.31%

Post 19:56 ET

71.47MMarket Cap-2600P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Vivani Medical Shares up 5.6% on Plans to Begin Human Trial for Obesity Implant
ReutersJul 11 09:34 ET
Express News | Vivani Medical Inc: Expects to Initiate First Clinical Study Supporting Npm-115 Program in Q4 of 2024
ReutersJul 11 08:00 ET
Express News | EXCLUSIVE: Vivani Tells Benzinga 'The NPM-115 Clinical Program Will Consist of a Series of Studies Designed to Support the Development of Vivani's Miniature, 6-month GLP-1 NanoPortalTM Implant for Chronic Weight Management in Obese or Overweight Patients'
BenzingaJul 11 07:30 ET
Express News | EXCLUSIVE: Vivani Medical Tells Benzinga 'Vivani Expects to Initiate the First Clinical Study Supporting the NPM-115 Program in the Fourth Quarter of 2024'
BenzingaJul 11 07:30 ET
Express News | EXCLSUIVE: Vivani Medical Tells Benzinga Co. Provides Update On Clinical Development Plans For Miniature, Long-Term, GLP-1 Obesity Implant Program, NPM-115
BenzingaJul 11 07:30 ET
EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
Vivani Medical Inc. (NASDAQ:VANI) expects to initiate the first clinical study for the NPM-115 program in Australia in the fourth quarter of 2024.The NPM-115 clinical program will evaluate the
BenzingaJul 11 07:29 ET

Comments

Trytosaveabit

Jul 11 09:41

Hmm?

$Vivani Medical(VANI.US)$ This is pretty bullish news! Oh well guess ill see! Hehehe

Trytosaveabit

Jul 11 06:31

Hmm

$Vivani Medical(VANI.US)$ EXCLSUIVE: Vivani Medical Tells Benzinga Co. Provides Update On Clinical Development Plans For Miniature, Long-Term, GLP-1 Obesity Implant Program, NPM-115

Trytosaveabit

Jun 13 07:02

News

$Vivani Medical(VANI.US)$ Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for Npm-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Trytosaveabit

May 28 06:35

News

$Vivani Medical(VANI.US)$ EXCLUSIVE: Vivani Medical Tells Benzinga Co Announces Publication Of Weight Loss Data Supporting Potential Veterinary Use Of OKV-119 Miniature, Long-Term GLP-1 Implant
EXCLUSIVE: Vivani Medical Tells Benzinga 'Felines Share Many Pathophysiologic Obesity Phenotypes With Humans, Further Supporting Clinical Evaluations of Miniature, Subdermal GLP-1 Implants for Obesity Reduction'